Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Grifols
Grifols
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Pharmaceutical
Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo over next seven years
Yimmugo will be followed by other proteins in the pipeline, including fibrinogen and trimodulin, both in late-stage development
Regulatory
Biotest’s Yimmugo receives FDA approval to treat primary immunodeficiencies
The immunoglobulin therapeutic has now been approved for treating primary immunodeficiencies in the US, following its acceptance into the European market
Regulatory
Grifols Procleix ArboPlex arbovirus screening assay receives CE mark
The assay can detect four major arboviruses: chikungunya, dengue, West Nile and Zika
Manufacturing
Spanish technology collaboration focuses on manufacturing equipment
Grifols and Mondragon will work on jointly developing medical and pharmaceutical-related automation, robotics and instrumentation
Manufacturing
Grifols to exhibit at CPhI Worldwide 2017
Grifols Partnership is a business to business contract development and manufacturing platform that specialises in small molecules intravenous solutions for the pharmaceutical industry
Design & Build
Grifols opens US$100m worldwide operations facility in Dublin, Ireland
Will contain a warehouse and handle labelling, packaging and final conditioning for plasma, intermediate and finished product
Design & Build
ISD completes cold storage facility for Spanish pharmaceutical firm Grifols
The 12-month project involved the design and construction of two temperature-controlled self-supporting structures
Subscribe now